Neuren Pharmaceuticals | NEU - Current Liabilities

Stock Price
11.40
Daily Change
-0.17 -1.47%
Monthly
-12.38%
Yearly
-7.32%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD4.34M in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Clinuvel Pharmaceuticals AUD 25.21M 4.17M Jun/2024
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Genetic Signatures AUD 4.78M 680K Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
Medical Developments International AUD 5.56M 2.26M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Paradigm Biopharmaceuticals AUD 3.23M 2.15M Jun/2025
PYC Therapeutics AUD 11.01M 1.31M Dec/2025
Starpharma Holdings AUD 4.61M 614K Dec/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Telix Pharmaceuticals AUD 231.62M 66.96M Dec/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025